Randomised clinical trial: a dose‐ranging study of vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis

類似資料

• Randomised clinical trial: vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis
  著者:: Ashida, K., 等
  出版事項: (2015)
• Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole
  著者:: Ashida, Kiyoshi, 等
  出版事項: (2018)
• Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects
  著者:: Jenkins, H, 等
  出版事項: (2015)
• Evaluating the cost-effectiveness of replacing lansoprazole with vonoprazan for treating erosive oesophagitis
  著者:: Laure de Preux, 等
  出版事項: (2025-09-01)
• A randomized, double-blind study to evaluate the acid-inhibitory effect of vonoprazan (20 mg and 40 mg) in patients with proton-pump inhibitor-resistant erosive esophagitis
  著者:: Iwakiri, Katsuhiko, 等
  出版事項: (2017)